ALBEMARLE CORP (ALB)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net sales | 1,329,992 | 1,076,881 | 1,354,692 | 1,430,385 |
| Cost of goods sold | 1,133,116 | 920,582 | 1,458,726 | 1,440,963 |
| Gross profit (loss) | 196,876 | 156,299 | -104,034 | -10,578 |
| Restructuring charges and asset write-offs | 4,448 | -1,063 | 828,146 | - |
| Research and development expenses | 12,444 | 14,099 | 22,397 | 20,770 |
| Selling, general and administrative expenses | 132,457 | 123,502 | 154,253 | 168,948 |
| Capital project assets write-off | - | - | - | 292,315 |
| Operating profit (loss) | 47,527 | 19,761 | -1,108,830 | -492,611 |
| Interest and financing expenses | 49,939 | 48,977 | 47,760 | 35,187 |
| Other (expenses) income, net | -6,559 | 10,250 | -22,256 | 33,666 |
| Loss before income taxes and equity in net income of unconsolidated investments | -8,971 | -18,966 | -1,178,846 | -494,132 |
| Income tax expense (benefit) | 34,094 | -3,978 | 110,853 | -30,660 |
| Loss before equity in net income of unconsolidated investments | -43,065 | -14,988 | -1,289,699 | -463,472 |
| Equity in net income of unconsolidated investments (net of tax) | 78,258 | 64,286 | 229,058 | 286,878 |
| Net income (loss) | 35,193 | 49,298 | -1,060,641 | -176,594 |
| Net income attributable to noncontrolling interests | 12,296 | 7,950 | 8,351 | 11,604 |
| Net income (loss) attributable to albemarle corporation | 22,897 | 41,348 | -1,068,992 | -188,198 |
| Mandatory convertible preferred stock dividends | 41,687 | 41,688 | 41,687 | 41,688 |
| Net loss attributable to albemarle corporation common shareholders | -18,790 | -340 | -1,110,679 | -229,886 |
| Basic loss per share attributable to common shareholders (in dollars per share) | -0.16 | - | -9.45 | -1.96 |
| Diluted loss per share attributable to common shareholders (in dollars per share) | -0.16 | - | -9.45 | -1.96 |
| Weighted-average common shares outstanding - basic (in shares) | 117,665,000 | 117,603,000 | 117,535,000 | 117,528,000 |
| Weighted-average common shares outstanding - diluted (in shares) | 117,665,000 | 117,603,000 | 117,535,000 | 117,528,000 |